1. Home
  2. FXNC vs MDWD Comparison

FXNC vs MDWD Comparison

Compare FXNC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$28.30

Market Cap

251.5M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$14.30

Market Cap

212.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
MDWD
Founded
1907
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
251.5M
212.1M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
FXNC
MDWD
Price
$28.30
$14.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
55.0K
99.1K
Earning Date
05-12-2026
05-20-2026
Dividend Yield
2.43%
N/A
EPS Growth
96.00
N/A
EPS
0.54
N/A
Revenue
$7,717,000.00
N/A
Revenue This Year
$12.21
$48.92
Revenue Next Year
$2.93
$35.04
P/E Ratio
$50.96
N/A
Revenue Growth
7.40
N/A
52 Week Low
$18.35
$13.54
52 Week High
$29.85
$22.00

Technical Indicators

Market Signals
Indicator
FXNC
MDWD
Relative Strength Index (RSI) 57.03 35.00
Support Level $26.39 N/A
Resistance Level $28.68 $18.49
Average True Range (ATR) 0.72 0.67
MACD 0.08 -0.24
Stochastic Oscillator 82.91 20.79

Price Performance

Historical Comparison
FXNC
MDWD

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: